Replimune Group, Inc. (REPL)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-08-20 | Astley-Sparke Philip | director | G | 50,000 | 0 | $0 |
| 2026-08-17 | Hill Emily Luisa | officer | S | 9,256 | 14.28 | $132,176 |
| 2026-08-10 | Patel Sushil | director | S | 39,341 | 12.97 | $510,253 |
| 2026-08-10 | Hill Emily Luisa | officer | S | 11,448 | 12.97 | $148,481 |
| 2026-08-10 | Xynos Konstantinos | officer | S | 11,447 | 12.97 | $148,468 |
| 2026-08-10 | Schwendenman Andrew | officer | S | 7,632 | 12.97 | $98,987 |
| 2026-06-01 | Sarchi Christopher | officer | S | 12,000 | 9.24 | $110,880 |
| 2026-06-01 | Sarchi Christopher | officer | S | 12,000 | 9.24 | $110,880 |
| 2026-05-18 | Xynos Konstantinos | officer | S | 14,023 | 5.08 | $71,237 |
| 2026-05-18 | Schwendenman Andrew | officer | S | 7,894 | 5.08 | $40,102 |
| 2026-05-18 | Sarchi Christopher | officer | S | 8,626 | 5.08 | $43,820 |
| 2026-05-18 | Astley-Sparke Philip | director | S | 17,657 | 5.08 | $89,698 |
| 2026-05-18 | Patel Sushil | director | S | 37,324 | 5.08 | $189,606 |
| 2026-05-18 | Hill Emily Luisa | officer | S | 7,812 | 5.08 | $39,685 |
| 2026-05-18 | Xynos Konstantinos | officer | S | 14,023 | 5.08 | $71,237 |
| 2026-05-18 | Schwendenman Andrew | officer | S | 7,894 | 5.08 | $40,102 |
| 2026-05-18 | Sarchi Christopher | officer | S | 8,626 | 5.08 | $43,820 |
| 2026-05-18 | Astley-Sparke Philip | director | S | 17,657 | 5.08 | $89,698 |
| 2026-05-18 | Patel Sushil | director | S | 37,324 | 5.08 | $189,606 |
| 2026-05-18 | Hill Emily Luisa | officer | S | 7,812 | 5.08 | $39,685 |
| 2026-04-02 | Sarchi Christopher | officer | S | 6,500 | 8.01 | $52,065 |
| 2026-04-02 | Sarchi Christopher | officer | S | 6,500 | 8.01 | $52,065 |
| 2026-04-01 | Sarchi Christopher | officer | A | 50,000 | 0 | $0 |
| 2026-04-01 | Astley-Sparke Philip | director | A | 50,000 | 0 | $0 |
| 2026-04-01 | Xynos Konstantinos | officer | A | 50,000 | 0 | $0 |
| 2026-04-01 | Schwendenman Andrew | officer | A | 36,667 | 0 | $0 |
| 2026-04-01 | Patel Sushil | director | A | 251,240 | 0 | $0 |
| 2026-04-01 | Hill Emily Luisa | officer | A | 50,000 | 0 | $0 |
| 2026-04-01 | Sarchi Christopher | officer | A | 50,000 | 0 | $0 |
| 2026-04-01 | Astley-Sparke Philip | director | A | 50,000 | 0 | $0 |
| 2026-04-01 | Xynos Konstantinos | officer | A | 50,000 | 0 | $0 |
| 2026-04-01 | Schwendenman Andrew | officer | A | 36,667 | 0 | $0 |
| 2026-04-01 | Patel Sushil | director | A | 251,240 | 0 | $0 |
| 2026-04-01 | Hill Emily Luisa | officer | A | 50,000 | 0 | $0 |
| 2026-02-18 | Astley-Sparke Philip | director | G | 25,000 | 0 | $0 |
| 2026-02-18 | Astley-Sparke Philip | director | G | 25,000 | 0 | $0 |
| 2025-12-19 | Patel Sushil | director | A | 200,000 | 0 | $0 |
| 2025-12-19 | Xynos Konstantinos | officer | A | 60,000 | 0 | $0 |
| 2025-12-19 | Hill Emily Luisa | officer | A | 60,000 | 0 | $0 |
| 2025-12-19 | Sarchi Christopher | officer | A | 35,000 | 0 | $0 |
| 2025-12-19 | Schwendenman Andrew | officer | A | 10,000 | 0 | $0 |
| 2025-12-19 | Patel Sushil | director | A | 200,000 | 0 | $0 |
| 2025-12-19 | Xynos Konstantinos | officer | A | 60,000 | 0 | $0 |
| 2025-12-19 | Hill Emily Luisa | officer | A | 60,000 | 0 | $0 |
| 2025-12-19 | Sarchi Christopher | officer | A | 35,000 | 0 | $0 |
| 2025-12-19 | Schwendenman Andrew | officer | A | 10,000 | 0 | $0 |
| 2025-12-09 | Dhingra Kapil | director | S | 3,169 | 10.4 | $32,958 |
| 2025-12-09 | Dhingra Kapil | director | M | 3,169 | 1.75 | $5,546 |
| 2025-12-09 | Dhingra Kapil | director | M | 3,169 | 1.75 | $5,546 |
| 2025-12-09 | Dhingra Kapil | director | S | 3,169 | 10.4 | $32,958 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-09-16 8-K
- 2026-08-24 4
- 2026-08-19 4
- 2026-08-14 S-3ASR
- 2026-08-14 10-Q
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-14 8-K
- 2026-08-12 4
- 2026-08-12 4
- 2026-08-12 4
- 2026-08-12 4
- 2026-08-11 SCHEDULE 13D/A
- 2026-08-11 4
- 2026-08-11 8-K/A
- 2026-08-10 SCHEDULE 13G
- 2026-08-10 8-K
- 2026-08-10 424B5
- 2026-08-07 SCHEDULE 13G
- 2026-08-07 8-K
- 2026-08-06 SCHEDULE 13G/A